Flu Treatment Market Growth, Trends, Share, Size, Opportunities and Future Scope 2022-2032
Flu Treatment Market Size- By Types, By Medication, By Route of Administration, By Distribution Channel, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2032
| Published: Feb-2023 | Report ID: HLCA2313 | Pages: 1 - 227 | Formats*: |
| Category : Healthcare | |||
Global Flu Treatment Market Overview
According to SPER Market Research, the Global Flu Treatment Market is estimated to reach USD 1.74 billion by 2032 with a CAGR of 5.25%.
Flu, commonly known as influenza, is a typical viral infection. Chills, aches in the muscles, fever, headaches, runny nose, cough, and others are common flu symptoms. The respiratory tract is primarily impacted by flu. Influenza viruses come in four main categories: influenza A, influenza B, influenza C, and influenza D. The influenza virus types A and B that cause seasonal flu most frequently each year are A and B. The market for influenza treatments has grown due to a number of causes, including an increase in healthcare spending and R&D spending on antiviral drugs. The expansion of government programmes to fight the flu and create reliable tests will support it. The rising cost of creating tests and equipment may restrain industry expansion. The limitations on accessibility and the availability of raw materials raise the cost of the final product.
Impact of COVID-19 on the Global Flu Treatment Market
The global market for flu medications is expanding as a result of ongoing advancements in technology and partnerships between private businesses and governmental agencies for the treatment of such pandemic flu. This is due to the Covid-19 disease, which is spreading continuously throughout the world and causing a significant number of deaths worldwide. Due to the global pandemic Covid-19, which has had a severe impact on a significant section of the population, the hospital pharmacies segment is predicted to exhibit the highest CAGR during the projection period. As a result, it is likely to encourage the market for flu medications to expand.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2032 |
| Base year considered | 2021 |
| Forecast period | 2022-2032 |
| Segments covered | By Type, By Medication, By Route of Administration, By Distribution Channel, By End User. |
| Regions covered | Asia-Pacific, Europe, Middle East and Africa, North America, Latin America |
| Companies Covered | AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GSK plc, Lilly, Merck & Co. Inc., Mylan N.V., NATCO Pharma Limited, Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd. |
Global Flu Treatment Market Segmentation:
1. By Type:
- Type A
- Type B
- Type C
2. By Medication:
- Antiviral drugs
- Antihistamines
- Analgesics
- Others
3. By Route of Administration:
- Oral
- Parenteral
- Others
4. By Distribution Channel:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
- Hospitals
- Homecare
- Specialty Clinics
- Others
6. By Region:
- Asia-Pacific
- Europe
- Middle East
- Africa
- North America
- Latin America
Key Topics Covered in the Report:
- Size of Global Flu Treatment Market (FY’2019-FY’2032)
- Overview of Global Flu Treatment Market
- Segmentation of Global Flu Treatment Market By Type (Type A, Type B, Type C)
- Segmentation of Global Flu Treatment Market By Medication (Antiviral drugs, Antihistamines, Analgesics, Others)
- Segmentation of Global Flu Treatment Market By Route of Administration (Oral, Parenteral, Others)
- Segmentation of Global Flu Treatment Market By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
- Segmentation of Global Flu Treatment Market By End User (Hospitals, Homecare, Specialty Clinics, Others)
- Statistical Snap of Global Flu Treatment Market
- Growth Analysis of Global Flu Treatment Market
- Problems and Challenges in Global Flu Treatment Market
- Competitive Landscape in the Global Flu Treatment Market
- Impact of COVID-19 and Demonetization on Global Flu Treatment Market
- Details on Recent Investment in Global Flu Treatment Market
- Competitive Analysis of Global Flu Treatment Market
- Major Players in the Global Flu Treatment Market
- SWOT Analysis of Global Flu Treatment Market
- Global Flu Treatment Market Future Outlook and Projections (FY’2019-FY’2032)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data2.1.2 Primary data2.1.3 SPER’s internal database2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers4.1.2 Restraints4.1.3 Opportunities4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Flu Treatment Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape5.2.2 Economic landscape5.2.3 Social landscape5.2.4 Technological landscape5.2.5 Environmental landscape5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers5.3.2 Bargaining power of Buyers5.3.3 Threat of Substitute5.3.4 Threat of new entrant5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Competitive Landscape
6.1 Global Flu Treatment Manufacturing Base Distribution, Sales Area, Product Type6.2 Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Flu Treatment Market
7. Global Flu Treatment Market, By Type, 2019-2032 (USD Million)
7.1. Type A7.2. Type B7.3. Type C
8. Global Flu Treatment Market, By Medication, 2019-2032 (USD Million)
8.1. Antiviral drugs8.2. Antihistamines8.3. Analgesics8.4. Others
9. Global Flu Treatment Market, By Route of Administration, 2019-2032 (USD Million)
9.1. Oral9.2. Parenteral9.3. Others
10. Global Flu Treatment Market, By Distribution Channel, 2019-2032 (USD Million)
10.1. Hospital Pharmacy10.2. Online Pharmacy10.3. Retail Pharmacy
11. Global Flu Treatment Market, By End User, 2019-2032 (USD Million)
11.1. Hospitals11.2. Homecare11.3. Specialty Clinics11.4. Others
12. Global Flu Treatment Market, By Region, 2019-2032 (USD Million)
12.1. Global Flu Treatment Market Size and Market Share by Region (2019-2025)12.2. Global Flu Treatment Market Size and Market Share by Region (2026-2032)12.3. Asia-Pacific
12.3.1. Australia12.3.2. China12.3.3. India12.3.4. Japan12.3.5. South Korea12.3.6. Rest of Asia-Pacific
12.4. Europe
12.4.1. France12.4.2. Germany12.4.3. Italy12.4.4. Spain12.4.5. United Kingdom12.4.6. Rest of Europe
12.5. Middle East and Africa
12.5.1. Kingdom of Saudi Arabia12.5.2. United Arab Emirates12.5.3. Rest of Middle East & Africa
12.6. North America
12.6.1. Canada12.6.2. Mexico12.6.3. United States
12.7. Latin America
12.7.1. Argentina12.7.2. Brazil12.7.3. Rest of Latin America
13. Company Profiles
13.1. AstraZeneca
13.1.1. Company details13.1.2. Financial outlook13.1.3. Product summary13.1.4. Recent developments
13.2. Bayer AG
13.2.1. Company details13.2.2. Financial outlook13.2.3. Product summary13.2.4. Recent developments
13.3. Bristol-Myers Squibb Company
13.3.1. Company details13.3.2. Financial outlook13.3.3. Product summary13.3.4. Recent developments
13.4. F. Hoffmann-La Roche Ltd.
13.4.1. Company details13.4.2. Financial outlook13.4.3. Product summary13.4.4. Recent developments
13.5. GSK plc
13.5.1. Company details13.5.2. Financial outlook13.5.3. Product summary13.5.4. Recent developments
13.6. Lilly
13.6.1. Company details13.6.2. Financial outlook13.6.3. Product summary13.6.4. Recent developments
13.7. Merck & Co. Inc.
13.7.1. Company details13.7.2. Financial outlook13.7.3. Product summary13.7.4. Recent developments
13.8. Mylan N.V.
13.8.1. Company details13.8.2. Financial outlook13.8.3. Product summary13.8.4. Recent developments
13.9. NATCO Pharma Limited
13.9.1. Company details13.9.2. Financial outlook13.9.3. Product summary13.9.4. Recent developments
13.10. Novartis AG
13.10.1. Company details13.10.2. Financial outlook13.10.3. Product summary13.10.4. Recent developments
13.11. Pfizer Inc.
13.11.1. Company details13.11.2. Financial outlook13.11.3. Product summary13.11.4. Recent developments
13.12. Sanofi
13.12.1. Company details13.12.2. Financial outlook13.12.3. Product summary13.12.4. Recent developments
13.13. Sun Pharmaceutical Industries Ltd.
13.13.1. Company details13.13.2. Financial outlook13.13.3. Product summary13.13.4. Recent developments
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Flu Treatment Market is projected to reach USD 1.74 billion by 2032, growing at a CAGR of 5.25% during the forecast period.
Flu Treatment Market grew in market size from 2021. The Market is expected to reach USD 1.74 billion by 2032, at a CAGR of 5.25% during the forecast period.
Flu Treatment Market CAGR of 5.25% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Flu Treatment Market size is USD 1.74 billion from 2022 to 2032.
Flu Treatment Market Segment is Covered By Type, By Medication, By Route of Administration, By Distribution Channel, By End User..
The North America region is anticipated to have the highest market share in the Flu Treatment Market.
The key players in the market include Companies Covered AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GSK plc, Lilly, Merck & Co. Inc., Mylan N.V., NATCO Pharma Limited, Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd.
The expansion of government programmes to fight the flu and create reliable tests will support it. The rising cost of creating tests and equipment may restrain industry expansion.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
